A new service from Aptamer Group promises to reduce biomarker discovery timelines from years to months, reshaping how pharmaceutical and diagnostic companies approach disease marker identification. The platform combines cutting-edge synthetic biology with advanced proteomics to deliver both validated biomarkers and functional binding tools simultaneously.
Siemens Healthineers has launched a comprehensive expansion of its 3gAllergy diagnostic capabilities, introducing nine new component allergens that deliver unprecedented precision in allergy management. Six of these target peanut allergies – the primary culprit behind fatal food-related anaphylaxis – whilst additional components address house dust mites and wheat sensitivities. This enhancement elevates the IMMULITE 2000 […]
FUJIFILM Biosciences has introduced BalanCD HEK293 Perfusion A Medium, the first commercially available cell culture solution specifically optimised for HEK293 cells in perfusion processes. The medium targets gene therapy applications, enabling continuous production of adeno-associated virus (AAV) and lentivirus (LV) vectors with enhanced consistency and scalability.
LUMICKS has launched Avidion, a next-generation Cell Avidity platform designed to address critical gaps in cell therapy development by measuring how immune cells physically engage with tumour targets.
Vapourtec has launched the Peptide-Builder, a benchtop solid-phase peptide synthesis (SPPS) system designed to streamline peptide production in research and clinical laboratories. The automated platform combines compact design with high-throughput capabilities, addressing space constraints whilst maintaining synthesis performance.
AMS Biotechnology (Amsbio) has unveiled an extensive collection of over 325,000 pre-characterised chemical compounds designed to accelerate drug screening applications across discovery and development programmes.
Radiometer, the urgent and acute care testing specialist, will join forces with Leica Biosystems and Cepheid to present a unified Danaher Diagnostics portfolio at IBMS Congress 2025. The collaboration, to be showcased on Stand 109 at Birmingham ICC from 22-25 September, demonstrates how point-of-care (POC) blood gas and immunoassay analysers can create a more connected […]
Natera has launched Fetal Focus™, a pioneering noninvasive prenatal test (NIPT) that screens for inherited conditions directly from maternal blood samples. This innovative diagnostic addresses a critical clinical gap when biological fathers are unavailable for carrier screening, transforming prenatal genetic testing capabilities.
Bio-Rad Laboratories has expanded its StarBright fluorescent dye portfolio with the introduction of StarBright UltraViolet700 (SBUV700), specifically engineered for spectral flow cytometry applications in immunology research. The new dye represents the first in a planned series rollout over the coming months, targeting enhanced panel design capabilities for clinical laboratories and research institutions.
TRIMERO Diagnostics offers IVD CE marked assays for testing Soluble Transferrin Receptor (sTfR).
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.